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ARTICLE
Loss-of-activity-mutation in the cardiac
chloride-bicarbonate exchanger AE3 causes short
QT syndrome
Kasper Thorsen1, Vibeke S. Dam2, Kasper Kjaer-Sorensen3, Lisbeth N. Pedersen1, V. Arvydas Skeberdis4,
Jonas Jurevičius4, Rimantas Treinys4, Ida M.B.S. Petersen5, Morten S. Nielsen5, Claus Oxvig3, J. Preben Morth6,7,
Vladimir V. Matchkov 2, Christian Aalkjær2,5, Henning Bundgaard8 & Henrik K. Jensen9,10
Patients with short QT syndrome (SQTS) may present with syncope, ventricular ﬁbrillation or
sudden cardiac death. Six SQTS susceptibility genes, encoding cation channels, explain <25%
of SQTS cases. Here we identify a missense mutation in the anion exchanger (AE3)-encoding
SLC4A3 gene in two unrelated families with SQTS. The mutation causes reduced surface
expression of AE3 and reduced membrane bicarbonate transport. Slc4a3 knockdown in
zebraﬁsh causes increased cardiac pHi, short QTc, and reduced systolic duration, which is
rescued by wildtype but not mutated SLC4A3. Mechanistic analyses suggest that an increase
in pHi and decrease in [Cl−]i shortened the action potential duration. However, other
mechanisms may also play a role. Altered anion transport represents a mechanism for
development of arrhythmia and may provide new therapeutic possibilities.
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The short QT syndrome (SQTS), ﬁrst recognized in 2000
1, is
a rare, genetically determined, severe arrhythmogenic dis-
ease with a high risk of syncope, atrial and ventricular
ﬁbrillation, and sudden cardiac death (SCD)2. Cardiac events
have a clear male preponderance, typically presenting during the
2nd or 3rd decade3. The treatment after aborted SCD and
malignant ventricular arrhythmia is implantable cardioverter
deﬁbrillator (ICD) implantation4. SQTS has only been reported to
present in an autosomal inherited dominant form. The diagnostic
criteria for SQTS proposed by Gollob et al.4 were based on a
combination of shortened duration of the repolarisation (QT
interval), family- and clinical history. A frequency corrected QT
(QTc)< 370 ms was suggested as an initial cutoff for diagnostic
consideration of SQTS, whereas the HRS/EHRA/APHRS Expert
Consensus Statement5 suggested QTc< 330ms as a stand-alone
criterion for the SQTS diagnosis or a possible diagnosis if QTc<
360 ms in combination with a pathogenic mutation, family- or
clinical history.
Disease-causing mutations have been identiﬁed in the cardiac
potassium ion channels KCNH26,7, KCNQ18 and KCNJ29 leading
to gain of channel function and causing action potential duration
(APD) shortening and elevated risk of cardiac arrhythmia. Loss-of-
function mutations in genes coding for the subunits of the cardiac
L-type calcium channels CACNA1C, CACNB2 and CACNA2D1,
have recently been identiﬁed as separate genetic causes of
SQTS10,11. So far, only these six cation channels have been impli-
cated in SQTS, and most expanded genetic screening therefore
focuses on cation channel genes. However, considering that iden-
tiﬁed cation channel mutations explain <25% of SQTS cases4, other
classes of genes are likely to be associated with the development of
this disease. Such genes may encode anion channels, transporters,
or proteins involved in pH regulation, which could all potentially
alter the QT interval. A role for changes in pH is supported by the
ﬁnding that lowering intracellular pH (pHi) prolongs QT inter-
val12; a role for Cl− is supported by the demonstration that mod-
ulation of Cl− conductance in cardiomyocytes also changes APD13.
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Fig. 1 Pedigrees and representative ECG recordings in two families with SQTS. a Pedigree of family 1 and 2. Proband marked with an arrow. b ECG recording
showing ventricular ﬁbrillation and DC shock conversion to sinus rhythm in the proband in family 1. c ECG-12 from the proband in family 1. d ECG-12 from
patient III-2 in family 2
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In this study, we identify a novel genetic etiology for SQTS in a
family with presumed autosomal dominant inheritance of SQTS.
We ﬁnd that affected family members have a mutation in the
anion exchanger Solute Carrier Family 4 Member 3 (SLC4A3)
gene, which encodes a Cl,HCO3-exchanger (AE3). The mutation
leads to a trafﬁcking defect, decreased Cl,HCO3-exchange over
the cell membrane, increased pHi and it reduces QT-duration in
zebraﬁsh embryos. These ﬁndings represent a previously unap-
preciated mechanism for the development of SQTS.
Results
Cardiac manifestations in probands and relatives with SQTS.
Pedigrees and demographics for the families are presented in
Fig. 1a and Supplementary Table 1. The index patient (III-17) in
family 1 presented 31 years old with cardiac arrest during sleep.
He was successfully resuscitated and admitted to hospital where a
new episode of ventricular ﬁbrillation was converted to sinus
rhythm by DC shock (Fig. 1b). In his ECG, a QTc duration of
320 ms and a J-point to T-peak interval (Jp-Tp) of 120 ms
(Fig. 1c) were noted. No other cardiac abnormalities were
observed. A structurally normal heart was found in all relatives,
except for subject IV-13, who showed dilated cardiomyopathy
with decreased systolic left ventricular ejection fraction (LVEF) of
40%. This patient was later diagnosed with Limb-Girdle muscle
dystrophy type 2I14. Four relatives (II-8, II-10, IV-1, III-13)
experienced syncopes in the second decade, and two relatives (III-
4, III-5) died suddenly and unexplained at the age of 41 and 42
years, respectively. In family 2, the proband (II-1) died suddenly
unexpectedly at rest 22 years old. His brother (II-2) was
asymptomatic with a structurally normal heart and a QTc of
320 ms and a Jp-Tp< 120 ms (Fig. 1d). The parents were
asymptomatic; the mother’s QTc was 355ms. Cascade screening
in family 2 revealed two more asymptomatic mutation-carrying
relatives (II-2, II-3) with short QTc’s in both (Fig. 1d and Sup-
plementary Table 1). All family members are of European
descent.
Whole exome sequencing of family members. Initial analysis of
the family 1 index patient using a targeted Next Generation
Sequencing (NGS) gene panel including the SQTS genes, known
to be associated with SQTS at that time (CACNA1C, CACNB2,
KCNH2, KCNQ1, and KCNJ2, Supplementary Table 2) revealed
no pathogenic mutations. Exome sequencing of four SQTS-
affected individuals from family 1 (III-17, IV-1, IV-3, IV-4) along
with four asymptomatic family members with normal ECGs (I-6,
II-6, III-16, IV-2) was performed (Fig. 1a). Three members from
family 2, who were referred to the clinic at the time of the ana-
lysis, were also exome sequenced (Supplementary Table 3).
Variants were ﬁltered to include variants shared by all six
SQTS individuals but not present in any of the ﬁve healthy
controls. After removal of variants observed in publicly available
databases (frequency> 5%) only 11 variants remained. Nine were
outside gene regions, one was intronic (chr19:52149499:
c421–11A>G, SIGLEC14), not predicted to affect splicing, and
one was a heterozygous missense variant (chr2:220497051:
c.1109 G>A NM_201574, p.R370H) in SLC4A3 (Supplementary
Table 3). The latter variant was not present in any of the
publically available variant databases. The resulting amino acid
change from arginine to histidine (R370H) is in the conserved
E367-T-A-R-W-I-K-F-E-E376 motif of the SLC4 family. The
variant was predicted as possibly damaging by PolyPhen215 and
had a CADD score 28.1 also indicating a deleterious effect of the
variant16.
ECG changes and manifestations in carriers and non-carriers.
Cascade screening in family 1 identiﬁed a total of 23 carriers of
the SLC4A3 c.1109 G>A variant. All carriers had a QTc≤
370 ms (mean 340± 18 ms) and 19 non-carriers had a QTc>
370 ms (mean 402± 24 ms) (p< 0.001, Students two-tailed t-test)
(Fig. 1a and Table 1). Post mortem analysis based on parafﬁn-
embedded tissue showed that subject II-2 also carried the
c.1109 G>A mutation, which makes the two relatively young
SCD victims (III-4 and 5) obligate carriers of the c.1109 G>A
variant. All SLC4A3 c.1109 G>A carriers had Jp-Tp ≤ 140 ms
(mean 121± 15 ms) compared to mean 173± 22 ms in non-
variant carriers (p< 0.001, Students two-tailed t-test). In the
unrelated smaller family 2, the four mutation-carrying relatives
had QTc< 370 ms. Only men and no children experienced clin-
ical symptoms. There were no differences in QTc (p= 0.78,
Students two-tailed t-test) or Jp-Tp (p= 0.97, Students two-tailed
t-test) between male and female carriers of the mutation
(Table 1). Due to the clinical course in these two families with
SCD and aborted SCD in the index patients and serious cardiac
syncope in another relative (Fig. 1a and Supplementary Table 1)
mutation carriers were offered implantation of a primary pro-
phylactic ICD. After thorough information, 16 out of 25 (64%) of
the asymptomatic mutation-carrying relatives, accepted ICD
implantation. After a follow-up of a mean of 49± 9 month none
Table 1 Electrocardiographic ﬁndings in SLC4A3 c.1109 G > A mutation carriers and non-carriers from a large family with short
QT syndrome
SLC4A3 c.1109 G > A (Mut) SLC4A3 Wild-type (WT) p-value
All individuals (Mut n= 23; WT n= 19)
QT (ms) 317± 25 378± 27 7.61E-09
QTc (ms) 340± 18 402± 24 2.13E-10
Jp-Tp (ms) 121± 15 173± 22 3.35E-09
Males (Mut n= 13; WT n= 9)
QT (ms) 323± 24 364± 27 5.39E-03
QTc (ms) 341± 19 391± 15 3.59E-06
Jp-Tp (ms) 121± 13 162± 16 2.65E-05
Females (Mut n= 10; WT n= 10)
QT (ms) 308± 23 391± 20 3.83E-07
QTc (ms) 339± 17 413± 26 4.57E-06
Jp-Tp (ms) 121± 18 182± 24 1.97E-05
Jp-Tp Jpoint-Tpeak interval, QT QT interval, QTc Bazett corrected QT interval
Data are presented as mean ± standard deviation
P-values determined by un-paired Students two-tailed t-test with Bonferroni’s correction
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of the mutation-carrying relatives including the aSCD survivor
had experienced ICD therapy. In addition, the mutation-carrying
relatives without an ICD were also asymptomatic.
Reduced membrane localization of the mutated AE3. We
functionally characterized the mutated AE3 variant in HEK-293
cells transfected with cDNA encoding wild-type AE3 or the AE3-
R370H mutant. No difference in expression of wild-type and
mutated AE3 was seen in whole cell lysates (Fig. 2a and Sup-
plementary Fig. 1), however, the surface localization of the
mutated protein was signiﬁcantly reduced compared to the wild-
type protein (Fig. 2b). This strongly suggests that trafﬁcking of
the mutated AE3 to the membrane was compromised.
Reduced Cl,HCO3-exchange activity of mutated AE3. Steady
state pHi was similar in HEK cells expressing wild-type AE3 and
mutated AE3 in both the presence and absence of HCO3−
(Fig. 2c). We next analyzed HCO3− transport in the two types of
cells (Fig. 2d, e). When assayed in the presence of HCO3−, the net
transfer rate of acid equivalents across the cell membrane fol-
lowing both omission of Cl− and addition of Cl− was faster in the
cells expressing wild-type AE3 compared to cells expressing the
mutated variant. In the absence of HCO3−, the transfer rates were
low and no difference was seen (Fig. 2d, e). These ﬁndings
indicate a loss-of-function effect of the mutation. Addition of
sodium acetate (NaOAc) was associated with a reduction of pHi
followed by recovery. When NaOAc was washed out, pHi
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test. Error bars throughout represent the s.e.m.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01630-0
4 NATURE COMMUNICATIONS | 8:  1696 |DOI: 10.1038/s41467-017-01630-0 |www.nature.com/naturecommunications
increased similarly in both groups. However, the following
decrease in pHi (in the presence of HCO3−) was signiﬁcantly
faster in cells expressing wild-type AE3 compared to cells
expressing the mutated variant (Fig. 2d, e), further supporting a
loss-of-function effect.
Elevated pHi and short QTc in AE3−deﬁcient zebraﬁsh hearts.
To determine the consequence of lacking AE3 activity in vivo, we
assessed the effect of slc4a3 knockdown on systolic contraction in
zebraﬁsh. Zebraﬁsh slc4a3 was efﬁciently knocked down in
embryos (Supplementary Fig. 2a). Whereas heart rates were
unaffected by the knockdown (Supplementary Fig. 2b and Sup-
plementary Fig. 2c), systolic contraction duration was sig-
niﬁcantly shortened (Fig. 3a). The phenotype was rescued by
mRNA encoding wild-type, but not Arg370His-mutated AE3,
demonstrating that amino acid residue Arg370 of AE3 is required
to maintain normal systolic duration in vivo (Fig. 3a, b).
Importantly, ECG analysis (Fig. 3c) demonstrated that the
observed shortening of systolic contraction corresponded to sig-
niﬁcantly shortened QTc for slc4a3 knockdown embryos (Fig. 3d)
which was associated with an increased ventricular pHi (Fig. 3e).
High pHi and low [Cl−]i shorten cardiac action potential. Due
to the increased pHi observed in embryonic slc4a3 knockdown
zebraﬁsh hearts, we tested whether increased pHi leads to shor-
tened APD and QTc in the isolated heart. Addition of 10 mM
NH4Cl extracellularly caused an increase of pHi in rabbit cardi-
omyocytes as expected (Supplementary Fig. 3). The increased pHi
was associated with a reduced APD of the cardiomyocytes
(Fig. 4a, b) and a shorter RT (Fig. 4c, d). Since AE3 mediates
HCO3− efﬂux in exchange for inﬂux of Cl−, we further tested
whether lowering of [Cl−]i shortens APD by patching rat ven-
tricular cardiomyocytes with 40 mM or 10 mM Cl− in the pipette
solution. As shown in Fig. 4e, 10 mM Cl− was associated with a
shorter APD compared to 40 mM Cl−.
Discussion
We report that a mutation in the SLC4A3 gene, which encodes
the cardiac chloride-bicarbonate exchanger AE3, is associated
with SQTS. Within a large affected family, the group of carriers
had experienced several serious cardiac events and SCD, whereas
no events had occurred in non-carriers. All carriers had a QTc≤
370 ms and all non-carriers had a QTc> 370 ms. The J-point to
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T-peak interval was≤ 140 ms in all carriers. Jp-Tp has been
suggested as a parameter to be applied in the diagnostic score of
SQTS4, and has been reported to have a high speciﬁcity for the
SQTS and is clinically readily recognizable on visual ECG
inspection. These ECG ﬁndings indicate a high penetrance as
assessed by repolarization duration, the equivalent of the APD. In
agreement with ﬁndings in other SQTS families, clinical mani-
festations were present in males only, and absent in children. Out
of 27 living mutation carriers from the two families, six showed
cardiac events considered SQTS related. The mutation leads to
reduced trafﬁcking of AE3 to the membrane, loss of
Cl,HCO3-exchange and increased pHi. The role of the mutation
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was emphasized by the identiﬁcation of the same mutation in an
unrelated family with SQTS and by the ﬁnding that slc4a3
knockdown in zebraﬁsh causes increased pHi, short QTc, and
reduced systolic contraction duration, which was rescued by
wildtype but not R370H-mutated AE3. Thus, our data show the
involvement of an anion transporter in the development of SQTS.
Previously, other SLC4A3 variants have been associated with
seizures17. Further, mice with a targeted disruption of the Cl,
HCO3-exchanger AE3 display a reduced threshold for triggering
an epileptic seizure18,19. However, none of the mutation-carriers
in our two families has had any clinical presentations with
unconsciousness suspected to be due to epileptic events. The case
with aSCD had documented VF.
AE3 is a comprehensively studied Cl,HCO3-exchanger with the
highest mRNA expression of the HCO3− transporters20 in mouse
hearts. AE3 is known to be important for myocardial pHi
recovery from alkaline loads20,21. However, AE3 knockout mice
show no overt cardiac phenotype unless crossed with Na,K,Cl
−exchanger knockout mice22 or mice carrying a mutation in α-
tropomyosin in a model of hypertrophic cardiomyopathy23. No
electrophysiological characterization of the hearts of the AE3
knockout mice has been published though.
The identiﬁed mutation of the SLC4A3 gene causes a single-
residue Arg-to-His change at amino acid position 370 of AE3,
which is part of the E367-T-A-R-W-I-K-F-E-E376 motif. This
motif is highly conserved in all SLC4 gene products24. Previously,
a Glu-to-Arg mutation in position 91 of NBCe1/SLC4A4 (posi-
tion equivalent to Glu375 of AE3)25 has been found to cause poor
surface targeting upon expression in MDCK cells. By analysis of
an NBCe1 homology model, Arg370 has been proposed to
interact with Glu376 (equivalent to Glu92 in NBCe1) through a
salt bridge26. We ﬁnd by further homology modeling that in
addition, Arg370 may form a cation-π interaction with Trp385
(Fig. 5). These two structural elements hint to a ﬁxed structural
environment that spatially orientates Arg370 and could lead to
misfolding if disrupted with a mutation to histidine. In agreement
with these data, we found that the mutated variant (Arg-370-His)
showed a level of translation similar to wild-type AE3, but only
poor surface targeting.
The reduced membrane trafﬁcking is strongly supported by the
reduced Cl,HCO3-exchange activity observed in transfected cells
expressing the mutated variant. The data therefore strongly
suggest that the mutation leads to trans-membraneous Cl− and
HCO3− transport deﬁcits, which might increase pHi and reduce
[Cl−]i.
There is some evidence that modulation of AE3 activity leads
to changes in pHi and [Cl−]i. In AE3 KO mice there is a tendency
to a higher steady state pHi in isolated cardiomyocytes compared
to pHi in cardiomyocytes from WT mice and the recovery time
from an imposed intracellular alkalosis is signiﬁcantly pro-
longed27. This is consistent with the effect of an inhibitory AE3
antibody on pHi in rat cardiomyocytes. Thus, in the presence of
endothelin-1, inhibition of AE3 increased pHi21. Additionally, α-
adrenergic receptor activation of the rat heart reduces steady state
pHi most likely through activation of AE328. These ﬁndings
indicate that in hearts expressing the mutated AE3, the capacity
to counteract an increase in pHi is compromised, particularly
under in vivo conditions where the heart is exposed to various
hormones and neurotransmitters. Our ﬁnding of an increased
steady state pHi in the hearts of zebraﬁsh embryos with knock-
down of AE3 is consistent with this. It has been suggested that
activation of AE3 during ischemia29 and extracellular acidosis30
contribute to the increase in guinea pig and sheep ventricular
muscle [Cl−]i. This indicates that the effect of AE3 on [Cl−]i may
also depend on conditions. Although these ﬁndings suggest that
inhibition of AE3 mediated anion transport leads to increased
pHi and decreased [Cl−]i this conclusion may need further
validation.
Since the AE3 mutation increased pHi and likely decreases
[Cl−]i, we tested the effects of increased pHi and decreased [Cl−]i
on myocyte electrophysiology. Increased pHi was associated with
a shortened APD in rabbit heart. This ﬁnding is consistent with
the ﬁnding of an APD prolongation by low pHi in rabbit ven-
tricular myocytes12. It is unclear how this effect is mediated.
However, high pHi activates Kv7.1 channels (KCNQ1)31,32, which
may accelerate repolarization. The knowledge about the effects of
high pHi on cardiac ion channels seems very limited. For KCNH2
we are not aware of studies addressing the effect of high pHi. For
the L-type Ca2+ channels the effect of high pHi is likely inhibi-
tion12 which would also accelerate repolarization.
We demonstrated that also reduced [Cl−]i leads to shortened
APD. A reduction of [Cl−]i will cause the equilibrium potential
for Cl− to be more negative and hence increase the Cl− inﬂux in
phase 2 and the beginning of phase 3 leading to a shorter action
potential. This ﬁnding is consistent with studies where different
Cl− channels in cardiomyocytes are inhibited33. Together this
demonstrates that low [Cl−]i due to inhibition of AE3 activity
might contribute directly to the SQTS.
We suggest that both high pHi and low [Cl−]i are likely to
contribute to the SQTS, but cannot exclude that other effects may
also contribute.
The low event rate during follow-up indicates the difﬁculties in
predicting the risk of ventricular arrhythmias or SCD in patients
with SQTS and underscores the importance of developing risk
scores. The clinical course of more families with AE3 mutations—
probably to be identiﬁed in the pool of SQTS patients with
hitherto negative genetic test results—will be needed to identify
AE3 mutation speciﬁc clinical risk factors.
In summary, we have identiﬁed a novel mutation in AE3 in
two independent families with SQTS. The mutation leads to
defective targeting of AE3 to the cell membrane, reduction of Cl,
HCO3-exchange and increased pHi. The impact of the mutation
on QTc duration was conﬁrmed in zebraﬁsh and the mechanism
through which a defect in Cl,HCO3-exchange leads to shortened
QTc likely relates to a combined effect of a decrease in HCO3−
Arg 370
Glu 376
Trp 385
Fig. 5 Molecular interaction in direct contact with Arg370. Glu376 is
forming a charged hydrogen bond to Arg370 (dashed black lines), while
Trp385 is linked through a cation-π interaction (orange dashed line). The
ﬁgure was prepared with The PyMOL Molecular Graphics System, Version
1.8 Schrödinger, LLC, and the modeling based on an alignment of the AE1
and AE3 sequence in the cytoplasmic region using PDB ID entry 1HYN as
template
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efﬂux (i.e., increased pHi) and a decrease in Cl− inﬂux. These
ﬁndings offer insight into mechanisms of arrhythmia in general
and may provide new treatment possibilities in patients with
SQTS. Currently, no speciﬁc factors triggering arrhythmia in
patients with SQTS have been reported. Based on this study,
possible triggers may include medications, physical activities,
metabolic derangements or diets challenging the Cl,HCO3-
exchange.
Further studies are required to determine the frequency of
involvement of SLC4A3 in SQTS and to delineate details of how
high pHi and low [Cl−]i may lead to the serious arrhythmia
associated with SQTS.
Methods
Patients and clinical evaluation. Informed consent was obtained from all subjects.
The study was approved by the Ethics Committee Central Denmark Region (no. 1-
10-72-189-16) and by the Danish Data Protection Agency (record no. 1-16-02-629-
16).
A 31-year old man resuscitated after cardiac arrest was diagnosed with SQTS4.
Cascade screening revealed a large family with 41 relatives to the proband.
Subsequently, another unrelated family with SQTS was included for veriﬁcation.
Clinical work-up included clinical examination, ECG, echocardiography, routine
blood tests and 48-hours Holter monitoring. Bazett corrected QT interval (QTc)
was used. Blood was collected from all family members for molecular genetic
analysis. In two cases, post-mortem genetic testing was performed.
Exome sequencing and data analysis. Genomic DNA was extracted from per-
ipheral leucocytes or parafﬁn tissue blocks on the QiaSymphony using standard
protocols (Qiagen). DNA from the index patient was initially analyzed with the
MOMA NGS Heart panel v1 (Custom EZ in solution DNA Capture, Nimblegen),
see Supplementary Table 2 for gene list using MiSeq sequencing (Illumina). For
whole exome sequencing 1 µg DNA was used for library preparation using the
TruSeq DNA LT Sample Prep Kit v2 according to the manufacturer’s instructions
(Illumina) followed by hybridization using Nimblegen SeqCap EZ Exome v3
(Roche) and Paired-end Sequencing (2 × 100 bp) on the Illumina HiSeq 2000 with
TruSeq v3 chemistry (Illumina). CLC BioMedical Genomics Workbench 2.1.1
(Qiagen) was used for data analysis and data was trimmed for adaptor sequence
and ambiguous bases before alignment to GRCh37, duplicate removal and SNV
and indel calling with the ﬁxed ploidy variant caller. Variants were uploaded to
Ingenuity Variant Analysis tool (Qiagen) and ﬁltered to exclude variants with an
allele frequency of at least 5% in either 1000 Genomes Project34, ExAC35 or NHLBI
ESP exomes (http://evs.gs.washington.edu/EVS). Finally, the variants shared by all
individuals with SQTS but not observed in any of the control samples were sub-
jected to further analysis. PCR ampliﬁcation and subsequent Sanger sequencing of
exon 8 containing the variant was used in all included family members for cascade
screening for the SLC4A3 variant.
Construction of AE3 R370H and gene expression. Human SLC4A3
(NM_201574) cDNA clone (Origen; Clone SC308062, US) was used as template for
introducing the mutation. The point mutation, was introduced using a phusion
site-directed mutagenesis kit (Thermo Scientiﬁc) and ampliﬁed with modiﬁed
DNA oligonucleotides (Europhins MWG) holding the mutation. Plasmid DNA
carrying either AE3 or AE3R370H (controlled for amplication errors) was trans-
fected into HEK-293 cells (ATCC, catalogue number CRL-1573) using TransIT-
LT1 transfection reagent (Mirus). Cells were shifted to selection media containing
600 µg ml−1 G418 (Sigma Aldrich) 48 h posttransfection. Cells for pHi experiment
were grown in poly-Lysine coated dishes.
AE3 surface processing and western blot analysis. Surface proteins were iso-
lated from HEK-293 cells using the biotinylation based Pierce cell surface protein
isolation kit (Thermo Scientiﬁc). Total protein cell lysate was prepared by resus-
pending and homogenizing cells in lysis buffer (10 mM Tris–HCl, 250 mM sucrose,
1 mM EDTA, 1 mM EGTA, 2% Triton X-100) containing Complete Mini, EDTA-
free protease inhibitor (Roche Applied Science, Germany, 1 tablet per 10 ml
solution). Protein concentration was assayed (Pierce BCA Protein Assay kit;
Thermo Scientiﬁc) and 10 µg of protein were solubilized in SDS-buffer and sepa-
rated by SDS-page. Proteins were transferred to PVDF membranes (Amersham;GE
Healthcare). Membranes were incubated with primary antibodies (Rabbit anti-AE3
(1:2000), kindly provided by Professor S. Alper, (Renal Division and Division of
Molecular and Vascular Medicine, Beth Israel Deaconess Medical Center, Boston,
USA), Rabbit-anti-pan-actin (1:2000), Cell Signaling Technology Inc., USA [Cat-
alog no. 4968]) overnight. Secondary antibody (goat-anti rabbit; Millipore, US
(1:2000)) linked to horseradish peroxidase were used to detect binding with the
ECL chemiluminescence system (Amersham; GE Healthcare).
pHi measurements in HEK-293 cells. Cells were loaded with 2 µM of the pH
sensitive dye BCECF-AM for 15 min in a physiological salt solution (PSS) at 37 °C.
The cells were placed on an Olympus IX70 microscope with an Olympus LUC-
PlanFL N 20× objective (N.A. 0.45) and an EasyRatioPro ﬂuorescence imaging
system (Photon Technology International). The cells were excited alternately at 485
and 440 nm and emission collected at 550 nm. The BCECF ratio between emission
light collected during excitation at 485 and 440 nm, respectively, was calculated
after subtraction of background ﬂuorescence and calibrated to pH units using the
high-K+ nigericin method, as previously described36. PSS contained in mM: 139
Na+, 5.9 K+, 1.6 Ca2+, 1.2 Mg2+, 122 Cl−, 25 HCO3−, 1.2 SO42−, 1.2 H2PO4−, 10
HEPES, 5.5 glucose and 0.026 EDTA. In HCO3− free solutions HCO3− was
replaced by Cl−. In Cl− free solution Cl− was substituted with aspartate. HCO3−
containing solutions were gassed with 5% CO2 in air; HCO3− free solutions were
gassed with air. All solutions were titrated to pH 7.4. After washout of BCECF-AM
steady state pHi was recorded and the solutions modiﬁed, as shown in Fig. 2d.
Intracellular buffering capacity was calculated from the change in pHi following
washing and washout of NaAcetate (NAOAc). The transport rate of acid equiva-
lents across the membrane was calculated from the change in pHi per unit time
multiplied by the buffering capacity.
Animal ethics. All animal experimental procedures were conformed to guidelines
from the European Convention for the Protection of Vertebrate Animals used for
Experimental and other Scientiﬁc Purposes and were approved by and conducted
with permission from the Animal Experiments Inspectorate of the Danish Ministry
of Environment and Food, and the State Food and Veterinary Service of the
Republic of Lithuania and Ethics Committee of the Lithuanian University of Health
Sciences.
Zebraﬁsh knockdown of slc4a3 and phenotyping. Adult zebraﬁsh of the AB
wildtype strain were fed four times daily and maintained on recirculating housing
systems on a 14 h light per 10 h darkness cycle at 28 °C. Embryos were obtained by
natural crosses and maintained in E3 medium (5 mM NaCl, 0.17 mM KCl,
0.33 mM MgSO4, 10–5% (w/w)methylene blue, 0.33 mM CaCl2, 2 mM Hepes pH
7.4) at 28 °C. Knockdown was performed by microinjection into zygotes of slc4a3-
targeted morpholino e7i7 (TCAGAAGGCTCAGCTCTCACCTCAT) or standard
control morpholino (CCTCTTACCTCAGTTACAATTTATA, Gene Tools, LLC).
e7i7 efﬁciency was assessed by reverse transcription PCR from cDNA synthesized
from total RNA extracted from groups of ten microinjected embryos two days post
fertilization (2 dpf) using primers 5′-CTTCGAGGACAATCCTGGGG-3′/5′-CTA
CGGAAGGACAGTGAGGC-3′ (slc4a3) and 5′-CACGAGACCACCTTCAACT-
3′/5′-ATCCAGACGGAGTATTTGC-3′ (β-actin). Human SLC4A3 mRNA was
in vitro synthesized using the mMessage mMachine T7 ULTRA kit (Ambion) with
linearized wild type (NM_201574) or R370H-mutated AE3-encoding plasmid as
template. Similar stability of microinjected wild type and mutant mRNA was
veriﬁed by RT-PCR on 2 dpf zebraﬁsh embryos using the human AE3-speciﬁc
primer set 5′-ATCATCACCCAACTCCCAGC-3′/5′- GGCACTTAGGAGGTCT
TGCC-3′.
For pHi measurements in isolated zebraﬁsh hearts, 2 dpf zebraﬁsh embryos
were brieﬂy anesthetized by rapid cooling on wet ice prior to the dissection of the
heart from the embryo. The isolated heart was immediately transferred to ﬁsh
buffer and the embryo was euthanized. The hearts were loaded with 5 µM BCECF-
AM for 5–15 min in ﬁsh buffer at room temperature. After washout of BCECF-AM
the recording and calibration of the ﬂuorescence signal from the ventricles of the
hearts were made as described for pHi measurements in HEK cells. The ﬁsh buffer
contained in mM: 131 Na+, 4.0 K+, 1.6 Ca2+, 127 Cl−, 10 HCO3−, 1.0 H2PO4−, and
5.0 glucose. The solution was gassed with 1% CO2 in air and pH was 7.65.
For assessment of cardiac function, 2 dpf embryos were anaesthetized using
buffered 150 ng mL−1 Ethyl 3-aminobenzoate methanesulfonate (MS-222, Sigma-
Aldrich) and staged in 4% methyl cellulose (average Mn ~ 86,000, Sigma-Aldrich)
in E3. To obtain systolic and diastolic durations, high-speed video recordings of
eight seconds duration at 100 frames per second were made. Video analysis was
performed, as previously described37,38 using an algorithm written in MATLAB
(The MathWorks Inc.) allowing for evaluation of ventricular contraction and
relaxation by quantiﬁcation of changing pixel intensity. Recordings were excluded
from analysis in cases where (1) atrial contraction/relaxation caused movement of
the ventricle interfering with quantiﬁcation of ventricular contraction/relaxation
and (2) the quality of recording, e.g., signal-to-noise ratio, did not allow
quantitative analysis. All embryos were euthanized by MS-222 overdose
immediately after phenotyping.
For ECG recordings two dpf zebraﬁsh embryos were placed in E3 medium with
MS-222 (150 ng mL−1) for ECG at room temperature (22–24 °C). The recordings
were made using a potassium acetate (3 M) ﬁlled borosilicate glass micropipette
(PG15OT-7.5; Harvard Apparatus) with tip resistances 5–10MΩ at 10 kHz using
an Axopatch 200B ampliﬁer (Axon Instruments, Inc.) in a current-clamp
conﬁguration. The recording electrode was positioned on embryo skin surface near
the heart (no penetration). Data acquisition was done with the software package
Clampex 7 for Windows (Axon Instruments Inc.). Data were analyzed in LabChart
7 (ADInstruments) after low-pass digital ﬁltering with cut-off frequency 50 Hz.
The ECG data were only excluded if the quality of recording, i.e., signal-to-noise
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ratio, did not allow quantitative analyzes of QT intervals. QT and RR intervals were
calculated for each embryo and converted to QTc.
Measurement of action potentials and ECG in rabbit heart. Experiments were
performed on six months old male New Zealand white rabbits (weight: 2.95±
0.18 kg, n = 5). Animals received 10 mg kg−1 xylazine (s.c.) following i.v. injection
of ketamine (10 mg kg−1) with heparin (1000 U kg−1). The heart was excised and
coronary arteries perfused in the Langendorff-system with oxygenated Tyrode
solution (in mM): 135 NaCl, 5.4 KCl, 1.8 CaCl2, 0.9 MgCl2, 0.33 NaH2PO4, 10
glucose, 10 HEPES, pH 7.4, 37 °C. In total 20 μM (−)-blebbistatin and 5 mM 2,3-
butanedione monoxime were added to stop contraction. The heart was stimulated
with bipolar silver electrodes in the left ventricle (LV) at 300 ms interval and 2 ms
square pulses of about twice diastolic threshold. ECG was recorded with two ECG
electrodes placed on LV (near the apex and near the base) using FE136 ampliﬁer
(ADInstruments) and digitized at 20 kHz.
The heart was stained with 50 μM di-4-ANBDQBS (JPW-6033) by slow 10ml
bolus injection. Optical recordings of action potentials (OAP), as described
previously39 were acquired with a cooled (−100 °C) 14-bit-EMCCD camera
(iXonEM +DU-860, Andor Technology) with a 50-mm focal length objective
(Navitar) and using the imaging software (Andor SOLIS). Collimated LED of
660 nm wavelength (M660L3, Thorlabs) was used for excitation of di-4-
ANBDQBS. Fluorescence emission was collected using long-pass ﬁlter of 720 nm
(HQ720lp, Chroma) with a sampling rate of 500 Hz. Background ﬂuorescence was
subtracted and 16 consequent recordings were averaged and normalized to the
control level. No exclusion criteria were applied to the data from the rabbit hearts.
Di-4-ANBDQBS was obtained from Dr L. Loew (University of Connecticut, USA).
LabChart8 Pro software (ADInstruments) was used to analyze the R-T interval
between R wave and 50% of T wave amplitude decrease. The optical movies were
preprocessed with the use of ImageJ software and OAPs were analyzed using MS
Excel Activation time of OAP was calculated as time between stimulus and 50% of
OAP upstroke amplitude; duration of OAP (OAPD)—time between 50% of OAP
upstroke amplitude and 50% of OAP repolarization time.
Recording of action potentials and ECG in rat cardiomyocytes. Ventricular
cardiomyocytes were isolated from male Sprague-Dawley rats (weight: 325± 8.3 g,
n= 13) (Taconic, Ll. Skensved, Denmark). Rats were anaesthetized using isoﬂurane
(5% in 100% O2), hearts were quickly excised and the aorta cannulated. Hearts
were retrogradely perfused by a solution containing in mM: 136 NaCl, 2.68 KCl,
1.47 KH2PO4, 8.06 Na2HPO4, 0.9 CaCl2, 0.9 MgCl2, 6 glucose, pH 7.4, equilibrated
with 100% O2 for 5 minutes, followed by 2 minutes of perfusion with the same
solution without calcium. Subsequently, perfusion was changed to a solution
containing (in mM) 20 NaCl, 120 K-gluconate, 1 MgCl2, 10 HEPES, 10 glucose, pH
7.4 equilibrated with 100% O2 for 2 min and perfusion with the same buffer added
96 Uml−1 collagenase (Type IV, Worthington), 25 µM CaCl2 and 0.1% BSA until
the tissue was digested. After the perfusion process, the heart was transferred to a
petri dish, the atria were discarded and the ventricles were cut into pieces. A
solution containing (in mM) 100 K-glutamate, 10 K-aspartate, 25 KCl, 10 KH2PO4,
2 MgSO4, 20 Taurine, 5 Creatine, 20 glucose, 0.5 EGTA, 5 HEPES, 0.1% BSA, pH
7.4 was used to cleanse the remaining pieces from collagenase and to stop the
digestive process. The pieces of ventricle were gently bubbled with 100% O2 to
dissolve the tissue and release the cardiomyocytes. Hereafter the solution was
ﬁltered using a metal grid (50 mesh) and washed. Ca2+ was gradually reintroduced
to a ﬁnal concentration of 0.72 mM and the cells were stored at 5 °C, until use on
the day of isolation. Action potentials were recorded in the whole-cell zero current
patch clamp conﬁguration using a SEC-05LX ampliﬁer (npi electronics, Tamm,
Germany). Signals were low-pass ﬁltered (current: 2 kHz; potential: 1 kHz) and
sampled at 10 kHz using CellWorks (npi electronics, Tamm, Germany).
The cardiomyocytes were superfused at room temperature with solution
containing in mM: 136 NaCl, 2.68 KCl, 1.47 KH2PO4, 8.06 Na2HPO4, 0.9 CaCl2,
0.9 MgCl2, 6 glucose; pH adjusted to 7.4. Borosilicate patch pipettes (3–5MΩ) were
ﬁlled with either 40 or 10 mM Chloride containing solution. The 40 mM Chloride
solution contained (in mM): 105 K-gluconate, 40 KCl, 9 Na-gluconate, 5 Na-
pyruvate, 1 Na2ATP, 1.92 MgSO4, 0.353 Ca-gluconate2, 1 EGTA, 5 HEPES, pH
adjusted to 7.2. For 10 mM Chloride, 30 mM KCl was exchanged with K-gluconate.
Action potentials were elicited at 1 Hz by current injection through the pipette for
ten minutes. The reported APD90 value is the average time to 90% repolarization
of the last 20 stimuli. Analyses were performed using a custom written script in
MatLab (MatLab R2013a, MathWorks, Inc.). Data from the patch clamp analysis
were excluded if the resting potential was unstable, in such cases depolarization
most often led to hypercontracture and loss of seal stability. These are standard
criteria for patch clamp experiments in our laboratory.
Statistics. Clinical data are presented as mean values± SD. Statistical signiﬁcant
differences between patient groups were ascertained by Students two-tailed t-test
for un-paired observations. Bonferroni’s correction was applied to correct for
multiple comparisons. Experimental data are presented as mean values± s.e.m.
Differences between means in the HEK cell and rat cardiomyocyte experiments
were tested with unpaired Student t-test. Differences between means in the zeb-
raﬁsh embryos were tested by unpaired Student t-test or one-way ANOVA with
Tukey’s post-test. Differences between means in the rabbit heart intracellular
alkalization experiments were tested with one-way repeated measures ANOVA.
p < 0.05 was considered signiﬁcant. All clinical and zebraﬁsh embryo data were
tested and found to be normally distributed. The pH measurements and the action
potential measurements are known from other experiments to have a normal
distribution.
Sample sizes were estimated based on previously published data for the
experiments on zebraﬁsh embryos, rabbit hearts, and rat cardiomyocytes. No
statistical method was used to determine sample size. No randomization or
blinding was applied to experiments involving zebraﬁsh embryos, rabbit hearts,
and rat cardiomyocytes.
Data availability. Exome sequencing data have been deposited in The European
Genome-phenome Archive under accession code EGAS00001002632. Access to the
sequence data needs to be approved by the local Data Access Committee.
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